The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Oct. 01, 2019
Filed:
Mar. 26, 2015
Applicant:
Millennium Pharmaceuticals, Inc., Cambridge, MA (US);
Inventors:
Rachael L. Brake, Natick, MA (US);
Viviana Bozon, West Newton, MA (US);
Ching-Kuo J. Chow, Littleton, MA (US);
James C. Dinunzio, Bridgewater, NJ (US);
Katherine M. Galvin, Newton, MA (US);
Karuppiah Kannan, Newton, MA (US);
Yuki Kodono, Osaka, JP;
Qunli Xu, Wellesley, MA (US);
Assignee:
MILLENNIUM PHARMACEUTICALS, INC., Cambridge, MA (US);
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 31/541 (2006.01); A61K 9/14 (2006.01); A61K 9/20 (2006.01); C12Q 1/6886 (2018.01); A61K 9/28 (2006.01);
U.S. Cl.
CPC ...
A61K 31/541 (2013.01); A61K 9/14 (2013.01); A61K 9/146 (2013.01); A61K 9/20 (2013.01); A61K 9/2027 (2013.01); A61K 9/2054 (2013.01); A61K 9/28 (2013.01); C12Q 1/6886 (2013.01); A61K 9/2866 (2013.01); C12Q 2600/106 (2013.01); C12Q 2600/156 (2013.01);
Abstract
The invention relates to a pharmaceutical composition comprising Compound 1 or a pharmaceutically acceptable salt thereof for the treatment of cancer and a process for its preparation. The invention also relates to administering the pharmaceutical composition to a patient according to an intermittent dosing regimen.